CNVVF - ConvaTec selects Veeva Vault CDMS for biomarker study

ConvaTec, a global medical products company providing therapies focused on managing chronic conditions, has picked Veeva (NYSE:VEEV) Vault CDMS to provide electronic data capture, coding, and data cleaning for their upcoming study on the detection of wound infections. A secondary objective is to explore the relationship between molecular microbiological analysis of swab samples and wound biopsies with the biomarkers pH, HNE, and MPO. It's a multi-center, international, analytical performance study expected to take ~20 weeks to complete and aims to enroll between 75 and 90 subjects.

For further details see:

ConvaTec selects Veeva Vault CDMS for biomarker study